FORSTER ELIOT received a stock award from PROTALIX BIOTHERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/4/2025ACC: 0001415889-25-023708
Director
Since Sep 2023
+22.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
22.50K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+7.50K
Price / share
—
Trade value
—
% of position
New position
9/3/2025
0.00→7.50K
Total
Net shares
+7.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/3/2025 | A · Award | +7.50K | — | — | New position | 0.00 | 7.50K |
| Total | +7.50K | $0.00 | ||||||
Derivative Transactions1
Stock Options (Right to Buy)
Direct
Converts to
Common Stock
15K shares
Shares
+15K
Strike price
1.64
Held after
15K
Exercisable
—
9/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) Direct | Common Stock15K shares | 9/3/2025 | A · Award | +15K | 1.64 | — | 15K |